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There is limited information about the true incidence of acute
renal failure (ARF). Most studies could not quantify disease
frequency in the general population as they are
hospital-based and confounded by variations in threshold
and the rate of hospitalization. Earlier studies relied on
diagnostic codes to identify non-dialysis requiring ARF. These
underestimated disease incidence since the codes have low
sensitivity. Here we quantified the incidence of non-dialysis
and dialysis-requiring ARF among members of a large
integrated health care delivery system –Kaiser Permanente of
Northern California. Non-dialysis requiring ARF was identified
using changes in inpatient serum creatinine values. Between
1996 and 2003, the incidence of non-dialysis requiring
ARF increased from 322.7 to 522.4 whereas that of
dialysis-requiring ARF increased from 19.5 to 29.5
per 100 000 person-years. ARF was more common in men
and among the elderly, although those aged 80 years or
more were less likely to receive acute dialysis treatment. We
conclude that the use of serum creatinine measurements to
identify cases of non-dialysis requiring ARF resulted in much
higher estimates of disease incidence compared with
previous studies. Both dialysis-requiring and non-dialysis
requiring ARFs are becoming more common. Our data
underscore the public health importance of ARF.
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Acute renal failure (ARF; also known as ‘acute kidney injury’)
is among the most important complications observed in
hospitalized patients. When severe enough to require dialysis,
ARF is associated with a high rate of in-hospital morbidity,
mortality, and prolonged length of stay.1 However, few
epidemiological studies have defined the incidence of ARF in
the community. A recent American Society of Nephrology
Renal Research Report identified as one of the ‘critically
important gaps in knowledge’ about ARF the fact that
‘incidence and prevalence of diseases are unknown.’2
We addressed this by determining the community-based
incidence of non-dialysis requiring and dialysis-requiring
ARF in a large, diverse cohort of patients receiving usual
medical care.
RESULTS
Between 1 January 1996 and 31 December 2003, a total of
3 787 410 members contributed 15 953 549 person-years of
observation. The average age of this cohort was 42.1715.8
years and 50.6% were women.
Incidence of non-dialysis requiring ARF
Overall, 61 280 subjects suffered non-dialysis requiring ARF,
yielding a disease incidence of 384.1 per 100 000 person-years
(95% confidence interval (CI) 381.1–387.2). The incidence of
non-dialysis requiring ARF increased over time (Figure 1),
and it was consistently higher in men than women and with
advancing age (Table 1).
Incidence of dialysis-requiring ARF
Over the same period, 3885 subjects suffered dialysis-
requiring ARF, yielding a disease incidence of 24.4 per
100 000 person-years (95% CI 23.6–25.1). The incidence of
dialysis-requiring ARF also increased over time (Figure 2). It
was also consistently higher in men than women and with
advancing age, although there was a drop off in incidence
among those persons aged X80 years (Table 2).
Results of chart validation
A review of medical records among a random sample of 100
subjects classified as having dialysis-requiring ARF showed
that 94 patients did receive dialysis for acutely worsening
kidney function. The remaining six cases were either patients
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receiving maintenance dialysis before hospital admission or
patients who did not receive dialysis.
DISCUSSION
Although ARF is one of the most common medical problems
encountered among hospitalized patients, much remains
unknown about its epidemiology, especially on a population
level. As stated in a recent review, such a basic epidemiologic
attribute as incidence of disease has remained ‘enigmatic and
debated.’3
A major reason for this gap in knowledge is that almost all
earlier studies of ARF have been based on hospitalized
patients or on the subgroup of patients in the intensive care
unit (ICU).4–8 Some studies only counted in the numerator
cases of ARF in the ICU that required renal replacement
therapy,6 which gives an incomplete picture of the actual
incidence of ARF. Others studies used as the denominator
hospitalization or ICU admission,4–8 which are suboptimal as
rates of hospitalization (or ICU admission) per population
are not defined – and these vary in different countries and
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Figure 1 | Community-based incidence rates (per 100 000
person-years) of non-dialysis requiring ARF by calendar year.
Table 1 | Community-based incidence rates (per 100 000 person-years) of non-dialysis requiring ARF (further stratified by
gender and age)
Overall rate (95% CI) By gender By age group
1996–2003 384.1 (381.1–387.2) Male: 443.1 (438.4–447.9) Ageo50: 78.0 (76.3–79.7)
Female: 330.4 (326.5–334.3) Age 50–59: 320.0 (313.2–326.9)
Age 60–69: 814.8 (801.3–828.3)
Age 70–79: 1809.1 (1783.5–1834.7)
AgeX80: 3545.4 (3481.4–3609.5)
1996–1997 322.7 (316.7–328.5) Male: 383.8 (379.4–397.9) Ageo50: 64.7 (61.4–68.0)
Female: 267.2 (259.9–274.5) Age 50–59: 224.5 (212.6–236.3)
Age 60–69: 597.8 (574.4–621.3)
Age 70–79: 1362.1 (1318.3–1405.9)
AgeX80: 2867.5 (2760.9–2974.2)
1998–1999 388.3 (382.1–394.5) Male: 451.8 (442.2–461.4) Ageo50: 72.9 (69.5–76.2)
Female: 330.5 (322.6–338.3) Age 50–59: 303.8 (290.4–317.3)
Age 60–69: 796.6 (770.0–823.3)
Age 70–79: 1813.2 (1762.2–1864.2)
AgeX80: 3796.3 (3665.5–3927.1)
2000–2001 453.6 (447.1–460.1) Male: 520.5 (510.4–530.6) Ageo50: 90.7 (87.1–94.3)
Female: 392.1 (383.8–400.5) Age 50–59: 393.7 (378.6–408.9)
Age 60–69: 985.9 (956.4–1015.4)
Age 70–79: 2220.7 (2164.1–2277.4)
AgeX80: 4388.0 (4293.9–4590.4)
2002–2003 522.4 (515.5–529.3) Male: 588.9 (578.3–599.4) Ageo50: 106.4 (102.6–110.2)
Female: 462.3 (453.3–471.2) Age 50–59: 483.8 (467.2–500.3)
Age 60–69: 1238.2 (1205.2–1271.3)
Age 70–79: 2741.3 (2677.1–2805.4)
AgeX80: 4884.3 (4722.8–5045.7)
ARF, acute renal failure; CI, confidence interval.
Bold indicates data for overall time period (1996–2003).
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Figure 2 | Community-based incidence rates (per 100 000
person-years) of dialysis-requiring ARF by calendar year.
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across time. For example, Hou et al.4 found among patients
from Tufts-New England Medical Center in Boston from
1978 to 1979 that the incidence of ARF was 4.9% per
hospitalization. Applying the identical criteria to patients
admitted to Rush Presbyterian-St Luke’s Medical Center,
Chicago in 1996, the same investigative team found that the
incidence of ARF was 7.2% per hospitalization.5 However, it
not possible to determine how much of this change is
influenced by variation in threshold for hospital admission
compared with underlying changes in the incidence of ARF.
In contrast, in this study, we are able to directly calculate
disease incidence relative to the source population.
Another strength of this study is that non-dialysis
requiring ARF was defined based on changes in serum
creatinine values. This is an advance over other epidemio-
logic studies which defined non-dialysis requiring ARF using
only claims data.7,9 Administrative data lack sensitivity in
identifying cases of non-dialysis requiring ARF, as it requires
both the recognition and coding of ARF. For example, using
the Hou et al. criteria for ARF as the ‘gold standard,’ Waikar
et al.10 determined that International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
codes for ARF had a sensitivity of only 28.3%. In an
independent sample, Liangos et al.11 concluded that sensi-
tivity was only 19.2%. Hence, estimates of the incidence of
non-dialysis requiring ARF from studies that rely on claims
data7,9,11 will substantially underestimate the true incidence
of ARF. This is possibly an important reason that the
observed incidence in our study is higher than previously
reported: 522.4 per 100 000 person-years observed here in the
calendar year 2002–2003 vs 288 per 100 000 person-years
reported by Waikar et al.9 during the same time period.
In addition to problems of underascertainment of disease,
claims data may be subject to bias from ‘code creep.’ Some
commentators have raised the concern that observed secular
trends in disease incidence are confounded by higher
likelihood over time of receiving a code for the same
condition or up-coding by using a more severe diagnostic
code to enhance financial reimbursement.12 In fact, ‘code
creep’ has been documented for ARF diagnostic codes.9
Defining disease using a change in serum creatinine should
lead to greater confidence that the observed increase in the
community-based incidence of non-dialysis requiring ARF
(Figure 1 and Table 1) is real and not an artifact of coding
bias.
Reliable quantification of the community-based incidence
of non-dialysis requiring ARF is needed to provide an
accurate estimate of the population attributable risk of non-
dialysis requiring ARF on the development of adverse clinical
outcomes, including mortality. Recently published studies
Table 2 | Community-based incidence rates (per 100 000 person-years) of dialysis-requiring ARF (further stratified by gender
and age)
Overall rate (95% CI) By gender By age group
1996–2003 24.4 (23.6–25.1) Male: 29.2 (28.0–30.4) Ageo50: 8.3 (7.7–8.8)
Female: 20.0 (19.0–20.1) Age 50–59: 27.8 (25.8–29.9)
Age 60–69: 61.1 (57.4–64.8)
Age 70–79: 95.6 (90.0–101.5)
AgeX80: 75.4 (66.0–84.7)
1996–1997 19.5 (18.1–21.0) Male: 23.2 (21.0–25.5) Ageo50: 6.4 (5.4–7.4)
Female: 16.2 (14.4–18.0) Age 50–59: 19.6 (16.1–23.1)
Age 60–69: 44.6 (38.2–52.0)
Age 70–79: 73.7 (63.5–83.9)
AgeX80: 65.1 (49.0–81.1)
1998–1999 21.7 (20.3–23.2) Male: 26.2 (23.9–28.5) Ageo50: 7.1 (6.1–8.1)
Female: 17.8 (16.0–20.0) Age 50–59: 23.1 (19.4–26.8)
Age 60–69: 51.6 (44.7–58.4)
Age 70–79: 89.2 (77.9–100.5)
AgeX80: 83.2 (63.9–102.6)
2000–2001 26.7 (25.1–28.3) Male: 31.5 (29.0–34.0) Ageo50: 9.2 (8.1–10.3)
Female: 22.3 (20.3–24.3) Age 50–59: 32.1 (27.8–36.4)
Age 60–69: 68.5 (60.8–76.3)
Age 70–79: 100.5 (88.5–112.6)
AgeX80: 95.3 (73.6–117.1)
2002–2003 29.5 (27.9–31.1) Male: 35.6 (33.0–38.2) Ageo50: 10.3 (9.1–11.5)
Female: 24.0 (22.0––26.0) Age 50–59: 36.8 (32.3–41.3)
Age 60–69: 81.5 (73.0–89.9)
Age 70–79: 123.2 (109.6–136.8)
AgeX80: 62.5 (44.2–80.75)
ARF, acute renal failure; CI, confidence interval.
Bold indicates data for overall time period (1996–2003).
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suggest that even relatively small changes in serum creatinine
during a hospital admission are associated with a dramatic
impact of short-term mortality risk.13,14 For example,
Chertow et al.13 showed that an increase in serum creatinine
of X0.5 mg/dl was independently associated with a 6.5-fold
increase in the odds of death, a 3.5-day increase in length of
stay, and nearly $7500 in excess hospital costs even after
adjusting for age, sex, and measures of comorbidity.
Although historically more attention has been focused on
dialysis-requiring ARF, our data indicate that the incidence of
non-dialysis requiring ARF is likely to be 10 to 20-fold
higher, which highlights its overall importance to individuals
and to the public health.
It should also be noted in this context that studying non-
dialysis requiring ARF rather than focusing solely on dialysis-
requiring ARF paints a more accurate picture of disease
distribution. The diagnosis of dialysis-requiring ARF can
only be made in cases when physicians ordered and patients
accepted dialysis. The juxtaposition of the incidence of
non-dialysis requiring ARF by age – which increases mono-
tonically with older age (Table 1) – and the incidence of
dialysis-requiring ARF – which drops off above 80 years
(Table 2) – suggest strongly that elderly persons are not
protected from ARF but rather, are far less likely to be
prescribed, or to accept, acute dialysis.
We observed that men have a higher incidence of non-
dialysis requiring ARF than women. One may argue that the
Hou et al. criteria are sex-biased in so far as men, who
generate more creatinine on average than women, are more
likely to reach a certain serum creatinine threshold given an
equivalent decrement in glomerular filtration rate (GFR).
However, differences in creatinine generation appear unlikely
to explain the observation that men also have a higher
incidence of dialysis-requiring ARF. Although numerous
studies have investigated sex differences in progression of
chronic kidney disease,15,16 few have investigated sex
differences in risk of ARF. Further studies are needed to
confirm this finding and to determine the underlying
explanations.
Our observed community-based incidence of dialysis-
requiring ARF – 29.5 per 100 000 person-years by calendar
year 2002–2003 – is considerably higher than what has been
noted in the older literature,17 but similar to more recent
reports.9,18,19 For example, Liano and Pascual17 found in a
9-month study conducted in 1991–1992 in Madrid, Spain
that the community incidence of dialysis requiring ARF was
7.5 per 100 000 person-years. In contrast, an 11-week Scottish
study conducted in 2000 by Metcalfe et al.18 determined that
the incidence of dialysis-requiring ARF was 20 per 100 000
person-years. US-based studies have also shown a steady rise
in the incidence of ARF over time. For example, data from
the Nationwide Inpatient Sample showed that the incidence
of dialysis-requiring ARF had increased from 4 to 27 per
100 000 person-years from 1988 to 2002.9 It is possible that
there are more cases of dialysis-requiring ARF because the
threshold for dialysis has become lower over time. This would
inflate the number of observed cases of dialysis-requiring
ARF but should not affect the incidence of non-dialysis
requiring ARF. Since the increase in incidence of dialysis-
requiring ARF does not appear greater than the increase in
incidence of non-dialysis requiring ARF (Figures 1 and 2), we
believe that the increase in ARF incidence is not artifactual.
The increase in ARF incidence may be a result of increase in
disease severity among hospitalized patients, improvements
in intensive care or expanded use of procedures, such as
percutaneous coronary interventions which predispose to
ARF.7,9,19 Again, both the incidence of non-dialysis requiring
ARF and the incidence of dialysis-requiring ARF are
increasing. This is another finding that has clinical, public
health, and policy implications.
There are several limitations to the study. First, the
selected definition of non-dialysis requiring ARF, although
widely adopted, might be considered arbitrary. We chose to
use the Hou et al. definition principally to allow direct
comparison with earlier published studies. Second, we may
have missed cases of dialysis-requiring ARF, as it was not
feasible to review medical records of all cases. However,
recent data show that administrative codes for dialysis-
requiring ARF have a sensitivity of over 90%.10 Missing cases
would, if anything, underestimate disease incidence and the
public health importance of dialysis-requiring ARF. The
high-positive predictive value for using administrative codes
to identify dialysis-requiring ARF shown by our 100 random
chart audit is consistent with earlier literature.10 Third, we
did not distinguish among different etiologies of ARF. The
so-called ‘pre- and post-renal’ causes are more likely to be
reversible and less likely to require dialysis than cases of
‘intrinsic’ ARF such as acute tubular necrosis.1 Fourth, as we
only used inpatient serum creatinine values to define ARF, we
may have missed cases of ARF that occurred in the outpatient
setting and did not require hospitalization. However, these
are likely to be relatively uncommon and are less important
from a clinical and public health point of view as they are not
associated with the high morbidity and mortality seen with
inpatient episodes of ARF. Finally, as our study was
conducted among insured members of a Northern California
integrated healthcare delivery system, our results may not be
generalizable to all other populations or health care settings.
In particular, patients without any form of health insurance
are not represented. However, our observed incidence of
dialysis-requiring ARF (29.5 per 100 000 person-years in
2002–2003) is very similar to that reported from a nationally
representative survey (27 per 100 000 person-years in 2002),9
which argues for greater generalizability.
In summary, we believe our study fills an important
knowledge gap by providing estimates of the incidence of
non-dialysis requiring and dialysis-requiring ARF among a
very large and diverse cohort of patients receiving usual
medical care. Using serum creatinine measurements to
identify cases of non-dialysis requiring ARF resulted in
higher – and we believe much more accurate – estimates of
disease incidence compared with earlier reports.
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MATERIALS AND METHODS
To determine the community-based incidence of ARF, our source
population included all adult members (X20 years old) enrolled in
Kaiser Permanente of Northern California (Kaiser), a large
integrated healthcare delivery system currently insuring more than
one third of the San Francisco Bay Area adult population. Its
population is representative of local surrounding and statewide
populations with only slightly lower-than population percentages at
the extremes of the socioeconomic spectrum and age.20
Kaiser delivers comprehensive inpatient and outpatient care to its
members and captures many aspects of its care through the use of its
comprehensive clinical and administrative databases. Fewer than
10% of hospitalizations in Kaiser members occur at a non-Kaiser
facility, and the majority of those patients are repatriated to a Kaiser
hospital early in their clinical course to complete their hospitaliza-
tion, which allows capture of relevant diagnoses and the majority of
procedures in this small subgroup of patients.
To calculate the incidence of ARF, the number of persons with
one or more episodes of ARF was divided by the number of persons
at risk. The number at risk was ascertained using annual health plan
membership information during the period from 1 January 1996 to
31 December 2003.
We cross-linked our study population with the nationally
comprehensive US Renal Data System (USRDS). At the time of
cross-linkage, USRDS data were complete through 31 December
2003. Supplementary determination of ESRD status was performed
using data from an internal Kaiser ESRD Registry.21 Patients with
known ESRD before hospitalization were excluded from our analysis.
Cases of non-dialysis requiring ARF were identified using inpatient
serum creatinine values. We used the Hou et al. criteria, which defined
ARF as an increase in serum creatinine level of 0.5 mg/dl for patients
with a baseline serum creatinine level of 1.9 mg/dl or less, 1.0 mg/dl
for patients with a baseline level of 2.0–4.9 mg/dl, and 1.5 mg/dl for
patients with a baseline level greater than or equal to 5.0 mg/dl. The
lowest serum creatinine level during the hospitalization was used as
the ‘baseline value,’ and renal insufficiency was defined relative to
that.4,5 Patients who met these criteria but also received dialysis using
that hospitalization were not counted (see below).
Cases of dialysis-requiring ARF were identified among patients
who were not on maintenance dialysis on admission but who
received dialysis during that hospitalization. After a review of the
literature and initial pilot testing, we used the International
Classification of Disease, Ninth Edition (ICD-9) procedure codes
54.98, 39.95, and Current Procedural Terminology (CPT) codes
90 935, 90 937, 90 945, 90 947, and 90 999 to identify episodes of
peritoneal dialysis and hemodialysis from health plan hospital
discharge databases. This approach was validated via a chart audit of
100 randomly selected episodes meeting these criteria.
Incidence of disease was presented as case per 100 000 person-
years. Confidence intervals were calculated using a large sample
approximation for Poisson rates.22 Given earlier literature regarding
possible differences in risk of ARF by age, sex, and calendar year,7,9
data are presented stratified by these variables.
The Institutional Review Boards of collaborating institutions
approved the study. Waiver of informed consent was obtained
because of the nature of the study.
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